Skip to main content
Erschienen in: PharmacoEconomics 2/2017

01.02.2017 | Practical Application

Emergent Challenges in Determining Costs for Economic Evaluations

verfasst von: Josephine C. Jacobs, Paul G. Barnett

Erschienen in: PharmacoEconomics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

This paper describes methods of determining costs for economic evaluations of healthcare and considers how cost determination is being affected by recent developments in healthcare. The literature was reviewed to identify the strengths and weaknesses of the four principal methods of cost determination: micro-costing, activity-based costing, charge-based costing, and gross costing. A scoping review was conducted to identify key trends in healthcare delivery and to identify costing issues associated with these changes. Existing guidelines provide information on how to implement various costing methods. Bottom-up costing is needed when accuracy is paramount, but top-down approaches are often the only feasible approach. We describe six healthcare trends that have important implications for costing methodology: (1) reform in payment mechanisms; (2) care delivery in less restrictive settings; (3) the growth of telehealth interventions; (4) the proliferation of new technology; (5) patient privacy concerns; and (6) growing efforts to implement guidelines. Some costs are difficult to measure and have been overlooked. These include physician services for inpatients, facility costs for outpatient services, the cost of developing treatment innovations, patient and caregiver costs, and the indirect costs of organizational interventions. Standardized methods are needed to determine social welfare and productivity costs. In the future, cost determination will be facilitated by technological advances but hindered by the shift to capitated payment, to the provision of care in less restrictive settings, and by heightened concern for medical record privacy.
Literatur
1.
Zurück zum Zitat Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
2.
Zurück zum Zitat Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
3.
Zurück zum Zitat Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.CrossRefPubMed Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.CrossRefPubMed
4.
Zurück zum Zitat Adam T, Koopmanschap MA, Evans DB. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care. 2003;19(2):407–20.CrossRefPubMed Adam T, Koopmanschap MA, Evans DB. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care. 2003;19(2):407–20.CrossRefPubMed
5.
Zurück zum Zitat Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S–91S.CrossRefPubMed Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S–91S.CrossRefPubMed
6.
Zurück zum Zitat Findorff MJ, Wyman JF, Croghan CF, Nyman JA. Use of time studies for determining intervention costs. Nurs Res. 2005;54(4):280–4 (pii:00006199-200507000-00011).CrossRefPubMed Findorff MJ, Wyman JF, Croghan CF, Nyman JA. Use of time studies for determining intervention costs. Nurs Res. 2005;54(4):280–4 (pii:00006199-200507000-00011).CrossRefPubMed
7.
Zurück zum Zitat Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3(6):1–76.PubMed Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3(6):1–76.PubMed
11.
Zurück zum Zitat Ross TK. Analyzing health care operations using ABC. J Health Care Finance. 2004;30(3):1–20.PubMed Ross TK. Analyzing health care operations using ABC. J Health Care Finance. 2004;30(3):1–20.PubMed
12.
Zurück zum Zitat Udpa S. Activity-based costing for hospitals. Health Care Manag Rev. 1996;21(3):83–96.CrossRef Udpa S. Activity-based costing for hospitals. Health Care Manag Rev. 1996;21(3):83–96.CrossRef
13.
Zurück zum Zitat Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–8, 50. Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–8, 50.
14.
Zurück zum Zitat Udpa S. Activity cost analysis: a tool to cost medical services and improve quality of care. Manag Care Q. 2001;9(3):34–41.PubMed Udpa S. Activity cost analysis: a tool to cost medical services and improve quality of care. Manag Care Q. 2001;9(3):34–41.PubMed
15.
Zurück zum Zitat Young DW. The folly of using RCCs and RVUs for intermediate product costing. Healthc Financ Manag. 2007;61(4):100–6, 8. Young DW. The folly of using RCCs and RVUs for intermediate product costing. Healthc Financ Manag. 2007;61(4):100–6, 8.
16.
Zurück zum Zitat Kaplan RS, Witkowski M, Abbott M, Guzman AB, Higgins LD, Meara JG, et al. Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag. 2014;59(6):399–412.PubMed Kaplan RS, Witkowski M, Abbott M, Guzman AB, Higgins LD, Meara JG, et al. Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag. 2014;59(6):399–412.PubMed
17.
Zurück zum Zitat Hunkeler EM, Hung YY, Rice DP, Weisner C, Hu T. Alcohol consumption patterns and health care costs in an HMO. Drug Alcohol Depend. 2001;64(2):181–90 (pii:S0376871601001193).CrossRefPubMed Hunkeler EM, Hung YY, Rice DP, Weisner C, Hu T. Alcohol consumption patterns and health care costs in an HMO. Drug Alcohol Depend. 2001;64(2):181–90 (pii:S0376871601001193).CrossRefPubMed
19.
Zurück zum Zitat Barnett PG, Rodgers JH. Use of the Decision Support System for VA cost-effectiveness research. Med Care. 1999;37(4 Suppl Va):AS63–70. Barnett PG, Rodgers JH. Use of the Decision Support System for VA cost-effectiveness research. Med Care. 1999;37(4 Suppl Va):AS63–70.
20.
Zurück zum Zitat Hill NT, Johns EL. Adoption of costing systems by U.S. hospitals. Hosp Health Serv Adm. 1994;39(4):521–37. Hill NT, Johns EL. Adoption of costing systems by U.S. hospitals. Hosp Health Serv Adm. 1994;39(4):521–37.
21.
Zurück zum Zitat Gehlert E, Jacobs JC, Barnett PG. Technical Report 32: costing methods used in VA research, 1980–2012. Menlo Park: VA Palo Alto, Health Economics Resource Center; 2016. Gehlert E, Jacobs JC, Barnett PG. Technical Report 32: costing methods used in VA research, 1980–2012. Menlo Park: VA Palo Alto, Health Economics Resource Center; 2016.
22.
Zurück zum Zitat Taira DA, Seto TB, Siegrist R, Cosgrove R, Berezin R, Cohen DJ. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145(3):452–8.CrossRefPubMed Taira DA, Seto TB, Siegrist R, Cosgrove R, Berezin R, Cohen DJ. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145(3):452–8.CrossRefPubMed
23.
24.
Zurück zum Zitat Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009; 47(7 Suppl 1):S51–55. Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009; 47(7 Suppl 1):S51–55.
26.
Zurück zum Zitat Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476–81.PubMed Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476–81.PubMed
27.
Zurück zum Zitat Phibbs CS, Bhandari A, Yu W, Barnett PG. Estimating the costs of VA ambulatory care. Med Care Res Rev. 2003;60(3 Suppl):54S–73S.CrossRefPubMed Phibbs CS, Bhandari A, Yu W, Barnett PG. Estimating the costs of VA ambulatory care. Med Care Res Rev. 2003;60(3 Suppl):54S–73S.CrossRefPubMed
30.
Zurück zum Zitat Barnett PG. Research without billing data. Econometric estimation of patient-specific costs. Med Care. 1997;35(6):553–63.CrossRefPubMed Barnett PG. Research without billing data. Econometric estimation of patient-specific costs. Med Care. 1997;35(6):553–63.CrossRefPubMed
32.
Zurück zum Zitat Chapko MK, Liu CF, Perkins M, Li YF, Fortney JC, Maciejewski ML. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ. 2009;18(10):1188–201. doi:10.1002/hec.1422.CrossRefPubMed Chapko MK, Liu CF, Perkins M, Li YF, Fortney JC, Maciejewski ML. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ. 2009;18(10):1188–201. doi:10.​1002/​hec.​1422.CrossRefPubMed
33.
Zurück zum Zitat Hardy KM, Kwong J, Pitzul KB, Vergis AS, Jackson TD, Urbach DR, et al. A cost comparison of laparoscopic and open colon surgery in a publicly funded academic institution. Surg Endosc. 2014;28(4):1213–22. doi:10.1007/s00464-013-3311-y.CrossRefPubMed Hardy KM, Kwong J, Pitzul KB, Vergis AS, Jackson TD, Urbach DR, et al. A cost comparison of laparoscopic and open colon surgery in a publicly funded academic institution. Surg Endosc. 2014;28(4):1213–22. doi:10.​1007/​s00464-013-3311-y.CrossRefPubMed
35.
Zurück zum Zitat Olsson TM. Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare. Eur J Health Econ. 2011;12(5):9.CrossRef Olsson TM. Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare. Eur J Health Econ. 2011;12(5):9.CrossRef
36.
Zurück zum Zitat Mogyorosy Z, Smith P. The main methodological issues in costing health care services: a literature review. York: University of York, Center for Health Economics; 2005. Mogyorosy Z, Smith P. The main methodological issues in costing health care services: a literature review. York: University of York, Center for Health Economics; 2005.
39.
Zurück zum Zitat Institute ECRI. Agency for Healthcare Research and Quality Healthcare Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Rockville: AHRQ; 2015. Institute ECRI. Agency for Healthcare Research and Quality Healthcare Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Rockville: AHRQ; 2015.
41.
Zurück zum Zitat Struijs JN, Mohnen SM, Molema CCM, de Jong-VanTil JT, Baan CA. Effects of bundled payment on curative health care costs in the Netherlands: an analysis for diabetes care and vascular risk management based on nationwide claim data, 2007–2010. Bilthoven: National Institute for Public Health and the Environment; 2012. Struijs JN, Mohnen SM, Molema CCM, de Jong-VanTil JT, Baan CA. Effects of bundled payment on curative health care costs in the Netherlands: an analysis for diabetes care and vascular risk management based on nationwide claim data, 2007–2010. Bilthoven: National Institute for Public Health and the Environment; 2012.
42.
Zurück zum Zitat Lix LM, Yao X, Kephart G, Quan H, Smith M, Kuwornu JP, et al. A prediction model to estimate completeness of electronic physician claims databases. BMJ Open. 2015;5(e006858):8. doi:10.1136/bmjopen-2014-006858. Lix LM, Yao X, Kephart G, Quan H, Smith M, Kuwornu JP, et al. A prediction model to estimate completeness of electronic physician claims databases. BMJ Open. 2015;5(e006858):8. doi:10.​1136/​bmjopen-2014-006858.
43.
Zurück zum Zitat Alshammari AM, Hux JE. The impact of non-fee-for-service reimbursement on chronic disease surveillance using administrative data. Can J Public Health. 2009;100(6):3. Alshammari AM, Hux JE. The impact of non-fee-for-service reimbursement on chronic disease surveillance using administrative data. Can J Public Health. 2009;100(6):3.
45.
Zurück zum Zitat Hilsenrath P, Eakin C, Fischer K. Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era. Inquiry. 2015;52. doi:10.1177/0046958015574981. Hilsenrath P, Eakin C, Fischer K. Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era. Inquiry. 2015;52. doi:10.​1177/​0046958015574981​.
46.
Zurück zum Zitat Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1–38. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1–38.
47.
Zurück zum Zitat Eiken S, Sredl K, Burwell B, Saucier P. Medicaid expenditures for long-term services and supports (LTSS) in FY 2013: home and community-based services were a majority of LTSS spending. Washington, DC: Medicaid.gov; 2015. Eiken S, Sredl K, Burwell B, Saucier P. Medicaid expenditures for long-term services and supports (LTSS) in FY 2013: home and community-based services were a majority of LTSS spending. Washington, DC: Medicaid.gov; 2015.
56.
Zurück zum Zitat Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.CrossRefPubMed Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.CrossRefPubMed
64.
Zurück zum Zitat Hoyle M, Anderson R. Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts. Med Decis Mak. 2010;30(4):426–37. doi:10.1177/0272989X09353946.CrossRef Hoyle M, Anderson R. Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts. Med Decis Mak. 2010;30(4):426–37. doi:10.​1177/​0272989X09353946​.CrossRef
67.
Zurück zum Zitat Gunn PP, Fremont AM, Bottrell M, Shugarman LR, Galegher J, Bikson T. The health insurance portability and accountability act privacy rule: a practical guide for researchers. Med Care. 2004;42(4):321–7 (pii:00005650-200404000-00004).CrossRefPubMed Gunn PP, Fremont AM, Bottrell M, Shugarman LR, Galegher J, Bikson T. The health insurance portability and accountability act privacy rule: a practical guide for researchers. Med Care. 2004;42(4):321–7 (pii:00005650-200404000-00004).CrossRefPubMed
68.
Zurück zum Zitat Shen JJ, Samson LF, Washington EL, Johnson P, Edwards C, Malone A. Barriers of HIPAA regulation to implementation of health services research. J Med Syst. 2006;30(1):65–9.CrossRefPubMed Shen JJ, Samson LF, Washington EL, Johnson P, Edwards C, Malone A. Barriers of HIPAA regulation to implementation of health services research. J Med Syst. 2006;30(1):65–9.CrossRefPubMed
69.
Zurück zum Zitat Hussey PS, Anderson GF, Osborn R, Feek C, McLaughlin V, Millar J, et al. How does the quality of care compare in five countries? Health Aff (Millwood). 2004;23(3):89–99.CrossRefPubMed Hussey PS, Anderson GF, Osborn R, Feek C, McLaughlin V, Millar J, et al. How does the quality of care compare in five countries? Health Aff (Millwood). 2004;23(3):89–99.CrossRefPubMed
70.
72.
Zurück zum Zitat Principal Investigators CTSA, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, et al. Preparedness of the CTSA’s structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012;5(2):121–9. doi:10.1111/j.1752-8062.2012.00401.x.CrossRef Principal Investigators CTSA, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, et al. Preparedness of the CTSA’s structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012;5(2):121–9. doi:10.​1111/​j.​1752-8062.​2012.​00401.​x.CrossRef
73..
Zurück zum Zitat Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care. 2000;38(6 Suppl 1):I17–25.PubMed Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care. 2000;38(6 Suppl 1):I17–25.PubMed
74.
Zurück zum Zitat Hoomans T, Evers SM, Ament AJ, Hubben MW, van der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health. 2007;10(4):305–16. doi:10.1111/j.1524-4733.2007.00175.x.CrossRefPubMed Hoomans T, Evers SM, Ament AJ, Hubben MW, van der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health. 2007;10(4):305–16. doi:10.​1111/​j.​1524-4733.​2007.​00175.​x.CrossRefPubMed
76.
Zurück zum Zitat Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care. 2003;12(5):366–71.CrossRefPubMedPubMedCentral Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care. 2003;12(5):366–71.CrossRefPubMedPubMedCentral
79.
Zurück zum Zitat Sathe NA, Nocon RS, Hughes B, Peek ME, Chin MH, Huang ES. The costs of participating in a diabetes quality improvement collaborative: variation among five clinics. Jt Comm J Qual Patient Saf. 2016;42(1):18–25.CrossRefPubMedPubMedCentral Sathe NA, Nocon RS, Hughes B, Peek ME, Chin MH, Huang ES. The costs of participating in a diabetes quality improvement collaborative: variation among five clinics. Jt Comm J Qual Patient Saf. 2016;42(1):18–25.CrossRefPubMedPubMedCentral
80.
Zurück zum Zitat Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals? JAMA. 2001;286(23):2988–92 (pii:jsc10303).CrossRefPubMed Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals? JAMA. 2001;286(23):2988–92 (pii:jsc10303).CrossRefPubMed
Metadaten
Titel
Emergent Challenges in Determining Costs for Economic Evaluations
verfasst von
Josephine C. Jacobs
Paul G. Barnett
Publikationsdatum
01.02.2017
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 2/2017
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-016-0465-1

Weitere Artikel der Ausgabe 2/2017

PharmacoEconomics 2/2017 Zur Ausgabe